← Back to Clinical Trials
Recruiting NCT05775627

NCT05775627 Sleep and Metabolism

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05775627
Status Recruiting
Phase
Sponsor Oregon Health and Science University
Condition Sleep Deprivation
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2023-12-01
Primary Completion 2027-06-30

Trial Parameters

Condition Sleep Deprivation
Sponsor Oregon Health and Science University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 18 Years
Max Age 40 Years
Start Date 2023-12-01
Completion 2027-06-30
Interventions
Sleep Restriction

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this study is to uncover sleep and circadian mechanisms contributing to adverse metabolic health. The protocol is a 21 day (7 outpatient days, 14 inpatient days) mechanistic randomized-crossover study designed to identify the impact of chronic sleep restriction and circadian timing, independently and in combination on energy metabolism and identify the independent and combined effects on glucose tolerance.

Eligibility Criteria

Inclusion Criteria: * Between 18 and 40 years of age * Drug free * Established disease-free status Exclusion Criteria: 1. Dietary restrictions Participants must not have dietary restrictions that could systematically bias their macronutrient intake. The following will exclude participants from enrolling in the study based on their diet: * Participants who choose not to or cannot consume dairy products (milk, yogurt, cheese, ice cream) 2. Body Composition A body mass index (BMI) of 18.5\< \[BMI\] \< 25 kg/m2 and a waist circumference \<94/80cm. 3. Psychiatric/psychological suitability Each participant will undergo a structured interview (Mini International Neuropsychiatric Interview) with a qualified OHSU physician. This physician will supervise the administration and scoring of a Beck Depression Inventory II (BDI-II) questionnaire for each potential participant. The following will exclude individuals from participating based on their psychiatric or psychological evaluation: * Individua

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology